Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMCQF) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to 9.75%.

  • Fresenius Medical Care AG's EBIT Margin rose 300.0% to 9.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.66%, marking a year-over-year decrease of 4500.0%. This contributed to the annual value of 7.2% for FY2024, which is 1600.0% up from last year.
  • Fresenius Medical Care AG's EBIT Margin amounted to 9.75% in Q3 2025, which was up 300.0% from 8.87% recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year EBIT Margin high stood at 11.37% for Q3 2021, and its period low was 5.09% during Q4 2024.
  • Its 5-year average for EBIT Margin is 8.28%, with a median of 8.58% in 2023.
  • Per our database at Business Quant, Fresenius Medical Care AG's EBIT Margin tumbled by -45800bps in 2021 and then soared by 31500bps in 2024.
  • Fresenius Medical Care AG's EBIT Margin (Quarter) stood at 10.51% in 2021, then fell by -26bps to 7.79% in 2022, then increased by 10bps to 8.58% in 2023, then crashed by -41bps to 5.09% in 2024, then soared by 92bps to 9.75% in 2025.
  • Its EBIT Margin stands at 9.75% for Q3 2025, versus 8.87% for Q2 2025 and 6.78% for Q1 2025.